Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid plus phototherapy for neonatal jaundice
IRCT20220723055524N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ursodeoxycholic acid in neonatal hyperbilirubinemia (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Reduction in serum bilirubin level and Length of hospitalization. Started Oct 2023; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20220723055524N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220723055524N1.